NYMOX PHARMACEUTICAL CORPORATION Revenue From Interest
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) reported Revenue From Interest of $2.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-06-03.
Financial Statements › Income Statement › Other Income
ifrs-full:RevenueFromInterest · last filed 2025-06-03
- NYMOX PHARMACEUTICAL CORPORATION revenue from interest for the quarter ending 2021-12-31 was $3.00K, a 50.00% increase year-over-year.
- NYMOX PHARMACEUTICAL CORPORATION revenue from interest for the quarter ending 2021-09-30 was $5.00K.
- NYMOX PHARMACEUTICAL CORPORATION revenue from interest for the quarter ending 2021-06-30 was -$6.00K.
- NYMOX PHARMACEUTICAL CORPORATION revenue from interest for the quarter ending 2020-12-31 was $2.00K.
| Period end | Revenue From Interest 3 month | Revenue From Interest 6 month | Revenue From Interest 9 month | Revenue From Interest 12 month |
|---|---|---|---|---|
| 2024-12-31 | $2.00K 20-F · filed 2025-06-03 | |||
| 2023-12-31 | $6.00K 20-F · filed 2025-06-03 | |||
| 2022-12-31 | $1.00K 20-F · filed 2025-06-03 | |||
| 2021-12-31 | $3.00K derived: 20-F 12 month − 6-K 9 month · filed 2024-08-29 | $8.00K derived: sum of 2 quarters · filed 2024-08-29 | $2.00K derived: sum of 3 quarters · filed 2024-08-29 | $8.00K 20-F · filed 2024-08-29 |
| 2021-09-30 | $5.00K 6-K · filed 2021-11-12 | -$1.00K derived: sum of 2 quarters · filed 2021-11-12 | $5.00K 6-K · filed 2021-11-12 | |
| 2021-06-30 | -$6.00K 6-K · filed 2021-08-13 | -$11.00K 6-K · filed 2021-08-13 | ||
| 2020-12-31 | $2.00K derived: 20-F 12 month − 6-K 9 month · filed 2023-05-02 | $1.00K derived: sum of 2 quarters · filed 2023-05-02 | -$7.00K derived: sum of 3 quarters · filed 2023-05-02 | $27.00K 20-F · filed 2023-05-02 |
| 2020-09-30 | -$1.00K 6-K · filed 2021-11-12 | -$9.00K derived: sum of 2 quarters · filed 2021-11-12 | $25.00K 6-K · filed 2021-11-12 | |
| 2020-06-30 | -$8.00K 6-K · filed 2021-08-13 | $13.00K 6-K · filed 2021-08-13 | ||
| 2019-12-31 | $213.00K 20-F · filed 2022-03-30 | |||
| 2018-12-31 | $72.00K 20-F · filed 2021-03-29 | |||
| 2017-12-31 | $11.00K 20-F · filed 2020-03-30 | |||
| 2016-12-31 | $4.00K 20-F · filed 2019-03-29 |